Dr. Alfares completed his medical school in Saudi Arabia and joined the medical genetics residency program at McGill University, Canada. Subsequently he joined Harvard Medical School in 2011 and completed two fellowships training in Clinical Molecular Genetics and Clinical Biochemical Genetics. Dr. Alfares currently working as an assistance professor at Qassim University, Saudi Arabia and as a consultant in medical genetics at National Guard Hospital. He is working on implementing high-throughput molecular genetics sequencing lab mainly for whole exome and genome within NGHA campuses also he is working as a consultant in the biochemical metabolic laboratory.
Senior Consultant of Medical Genetics PSMMC;adjunct principal scientist, KFSH&RC, Professor of Medical Genetic, Alfaisal University, Riyadh and American University of Beirut, Lebanon
Board Member of the International Society of Stem Cell Research (ISSCR) Ethics and Public Policy Committee
Founder of the Medical Genetic, Metabolic, and Endocrinology service and Division, PSMMC
One of the Founders of the newborn screening pilot program in Saudi Arabia
One of the Founders of the Middle East Medical Genetics Group
International Judge, Scientific Selection Committee Member, King Faisal International Prize in Medicine
Author of Atlas of Inherited Metabolic Diseases book and Genomics and Health in the Developing World.
Awarded over 10 international awards including, the Outstanding Investigator Award from the American Federation of Medical Research, February 2002, Young Scientist Award from European Society of Human Genetics, May 2005, the Outstanding Young Investigator Award from the 10th International Congress of Inborn Errors of Metabolism, Chiba, Japan, Sept 2006 in the presence of HRH Prince Narohito, the Crown Prince of Japan. I was honored at the House of Commons, United Kingdom, as one of distinctive international speakers, July 2007. Awarded the Distinction Medal by HRH Prince Sultan Bin Abdulaziz, the Crown Prince of Saudi Arabia 2008; the Distinctive Arab Female Scientist Prize by the Arabian Gulf University, Bahrain, May 2009; the King Faisal Distinction Wissam by the Custodian of the Two Holy Mosques, King Abdullaha Bin AbdulAziz January 2010; and the Prince Sultan International Award for the Pioneers of Saudi Medical Innovations and Creativity, October 2010.
Involved in several research projects including Embryonic stem cell research, for which she is a warded 35 millions Saudi Riyals by King Abdulaziz City for Science and Technology.
Presented over 200 papers to National and International meetings, been invited to teach and lecture to several Universities and conferences including: Havard Medical School; North Western University; Mount Sinai School of Medicine; Yale University; University of California, Irvine, USA; Ain Shams University, Egypt; American University of Beirut, Lebanon; Damascus University, Syria; Kuwait University; First International Congress of Women in Science, Moroco; World Health Organization, Geneva; Centre of Disease Control, USA; University of Oslo and Medical Advisory Board of Biotechnology, Oslo, Norway; National Institute of Health (NICHD), USA; Ministry of Health, Morocco; Wellcome Trust Foundation ,Cambridge, UK; Nanotechnology conference, Doha, Qatar; Human Variome Panel of experts; NIH, WHO, Brocher Foundation Newborn Screening Panel of experts, Human Genome Meeting 2011 among others. Published over 80 papers
Alison Lashwood trained in paediatric and adult nursing before undertaking a Masters in Genetic Counselling. She is a Genetic Counsellor and Clinical Lead (Genetics) for the PGD service at Guy’s Hospital. She set up the PGD service with Professors Peter Braude & Yacoub Khalaf which started in 1997 and helped develop the unique Genetics and Assisted Reproduction integrated team that represents the PGD service at Guy’s today. She has worked in a strategic and clinical role since and has helped build the PGD service into one of the leading PGD units in Europe. This is a service which now includes PGD for single gene and chromosome disorders, PGD with fertility preservation and PGD with Human Leucocyte Antigen testing.
From 2007-2009 she was a member of the PGD Steering Committee with a special interest in the paediatric follow up of children born after PGD and was a co-author of the ESHRE Best Practice Guidelines for PGD (2011). Alison has written a number of chapters on PGD genetic counselling for publication including Preimplantation Genetic Diagnosis (Harper 2009), Textbook of Human Reproductive Genetics (Sermon & Viville, 2014) and Preimplantation Genetic Diagnosis in Clinical Practice (El-Toukhy & Braude, 2014)
Alison’s other professional interests include genetic counselling for late onset disorders and prenatal diagnostics.ric follow up studies. She has presented at numerous international conference on PGD.
MD, DCH (IRE), MRCP(UK), PhD (UK),
Consultant Clinical Geneticist,
Founder of National Genetic Center,
Sultanate of Oman.
Dr. Therrell is currently working as an international newborn screening consultant and Director of the National Newborn Screening and Global Resource Center in Austin, Texas. He has been active in newborn screening for over 45 years including, initiating and hosting the 1st U.S. National Newborn Screening Symposia in 1981, supervising one of the largest newborn screening laboratories in the world at the Texas Department of Health for over 28 years, and serving as Professor of Pediatrics at the University of Texas Health Science Center at San Antonio and Director of the US National Newborn Screening and Genetics Resource Center for over 13 years. Dr. Therrell is actively involved in providing program expert advice to newborn screening programs both in the U.S. and in developing countries. He has reviewed over 45 state newborn screening programs for the U.S. Health Resourcs and Services Administration, with an eye towards program refinement, and has completed over 25 missions as an expert newborn screening project reviewer for the International Atomic Energy Agency advising on laboratory and infrastructure implementation in developing countries.
Dr. Therrell hosts an international listserv dedicated to exchanging meaningful newborn screening information worldwide. He is a founding member of the International Society for Neonatal Screening (ISNS), and served as its first Secretariat (2 terms) and second President (2 terms). He has authored or co-authored over 175 articles in scientific journals, several books and book chapters, and has presented over 200 invited international lectures. His recent interests center around screening program development and overcoming barriers to implementation in developintg countries.In 1997, Prof. Therrell was awarded an Honorary Doctor of Medicine Degree by Kunming Medical College Kunming, Yunnan, People’s Republic of China for his work in improving Chinese-American relations in newborn screening. In 2000, he received the ISNS prestigious ‘Guthrie Award’ for his outstanding work in international newborn screening activities. He received the ‘Alumnus of the Year’ award in 2009 from Mississippi College and the ‘Visionary Award’ in 2011 from the CARES Foundation (parent support group for congenital adrenal hyperplasia).
Dr. Brian Meyer is currently Chairman of the Department of Genetics in the Research Centre of King Faisal Specialist Hospital and Research Centre (KFSHRC). He is an Australian citizen and undertook his undergraduate and postgraduate studies at the University of Western Australia. He has worked at KFSHRC for 18 years studying primarily the genetic basis of recessive Mendelian diseases and has authored more than 100 related articles in peer reviewed journals. Results from many of these studies undertaken by scientists in the Department of Genetics have led to the development of molecular genetic testing specific to Arab populations. Dr. Meyer is one of the founding scientists of Saudi Diagnostic Laboratories and has introduced to the region cutting edge technologies in molecular diagnostics, carrier screening and preventative procedures such as prenatal testing. Prior to joining KFSHRC, Dr. Meyer was responsible for the Cytogenetics and Bone Marrow Transplant Laboratories in the hematology department at Royal Perth Hospital. During this time he was actively involved in transplantation and molecular oncology research and developed several monoclonal antibodies for research purposes. Currently his role involves oversight of the Saudi Human Genome Program, a Clinical Genomics initiative for implementation of Precision Medicine and a unique population based pre-marital screening program for the prevention of inherited diseases.
Dr. Padilla is Professor of Pediatrics and Chancellor of the University of the Philippines Manila. Dr. Padilla is a pioneer in genetics in the Philippines and the Asia Pacific region. In the Philippines, she is responsible for setting up the clinical genetic services at the Philippine General Hospital in 1990 and the various genetic laboratories now housed at the Institute of Human Genetics – NIH (www.ihg.upm.edu.ph). She is also responsible for setting up of national newborn screening services in the Philippines, currently available in 6800+ health facilities in the country. In the Asia Pacific region, Dr. Padilla is part of the pioneering group that established the Asia Pacific Society for Human Genetics and she served as president in 2008-2010. Dr. Padilla is Council member of the Human Genome Organization, an international organization of scientists from 69 countries (www.hugo-international.org). As Academician since 2008, she was appointed country representative in 2010 to the InterAcademy Medical Panel, a global network of more than 60 academies in the world. (http://www.iamp-online.org/)
Dr Padilla has more than 120 publications (original articles, chapters in textbook and non-textbooks, training modules, etc). In the area of policy making, she is responsible for the Newborn Screening Act of 2004 (Republic Act 9288) and Rare Disease Act of 2016 (Republic Act 10747). She is currently lobbying for the passage the comprehensive program for folic acid supplementation and fortification.
David S. Millington, PhD, is Emeritus Professor of Pediatrics, recently retired from Duke University School of Medicine after 33 years of service. He and his colleagues pioneered the application of tandem mass spectrometry for the targeted analysis of acylcarnitines that became a frontline diagnostic test for defects of fat oxidation and branched-chain amino acid catabolism. Subsequently, the method was modified to include several essential amino acids and applied to dried blood spots, paving the way for the expansion of newborn screening for from a handful to over 30 metabolic conditions. Dr. Millington has developed educational material and taught many laboratorians and follow-up coordinators worldwide how to apply MSMS technology and interpret results. He has also helped to pioneer novel enzymatic and biomarker assays for numerous lysosomal storage conditions to facilitate patient diagnosis and monitoring. Dr Millington has published over 200 research articles and book chapters and has served on the North Carolina Newborn Screening Program Advisory Board since 1990. He was honored jointly with Dr Mohamed Rashed by the ISNS with the Robert Guthrie award for outstanding contributions to newborn screening in 1996. He was also honored by the MSACL in 2015 with their first Distinguished Contribution Award in recognition of achievements made in the field of clinical mass spectrometry.
|Field of Study||College / University (Country)||Degree|
|Biology (1979-1983)||University of North Texas, Denton, Texas||B.S. Biology|
|Medical Technology (1980-1984)||University of North Texas, Denton, Texas||B.S. Medical technology|
|Degree||Field of Study||College / University (Country)||Y. of Graduation|
|PhD||Molecular Biology, Double minor in Human Genetics & Biochemistry||University of North Texas, Denton, Texas||1989|
|Period||Position / Function||Institution|
|2006-present||Professor, Head & Director of Genetics Research Center (GRC)||Genetics Research Center, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran|
|2002 - 2006||Associate Professor, Head & Director of GRC||Genetics Research Center, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran|
|1996-2002||Assistant Professor, Head & Director of GRC||Genetics Research Center, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran|
|1995-1996||Assistant Professor of Medicine||Charles Drew University of Medicine & Science – UCLA, Los Angeles, CA, USA|
|1990-1995||Postdoctoral fellow||Harbor – UCLA Medical Center, Torrance, CA, USA|
J. Andoni URTIZBEREA, (MD, MSc), aged 59, is certified both in paediatrics and PMR (physical medicine and rehabilitation) from Paris University, France. He graduated in parallel from the Institut d’Etudes Politiques de Paris in 1987 cum magna laude inn 1984. As former Scientific Director of the European Neuromuscular Center (ENMC) and Medical Director of the AFM-Telethon (the French Muscular Dystrophy Association) in the 90s, he contributed to the establishment of many worldwide networks in myology, an emerging discipline focused on muscle diseases. JAU is currently a part-time clinical neuromyologist in Hendaye, south of France (Hôpital Marin, APHP) and deputy coordinator of the French Neuromuscular Network (FILNEMUS) in Marseilles. Over the past twenty years, JAU headed various worldwide educational events dedicated to myology in France (the renowned Summer School of Myology of Paris) but also in Latin America, Russia and, more recently in the Middle-East. As a regular visiting professor for the Ministry of Health of Kuwait, he knows particularly well the Middle-East and the Indian subcontinent. Ideally placed at the intersection of industry, patient advocacy groups and academia, his main objective is to raise more awareness about these rare conditions notably in emerging countries, more specifically in the context of novel cutting-edge therapies. His main fields of interest are SMA (spinal muscular atrophies), Duchenne muscular dystrophy and Pompe disease.
Division chief- Paediatric Pulmonology (November 2015- to date)
Paediatric Pulmonologist (March 2007- November 2015)
Royal Manchester Children’s University Hospital
Royal Manchester Children’s University Hospital, with 371 beds, is the largest single site Paediatric Hospital in UK. I am one of the 4 full time Paediatric Pulmonologists at Royal Manchester Children’s Hospital. Paediatric Respiratory unit at Royal Manchester Children’s Hospital provide inpatient care for an average of 30-55 patients at one time. We have 3 Specialist Registrars and 3 Senior House Officers in our unit.
My clinical commitments are: 4 Outpatient clinics a week, twice a week ward rounds and day to day review of patients as needed. I perform both Elective and Emergency Bronchoscopies. Working in a University Hospital my duties also include Medical student, Senior House Officer and Registrar teaching and supervision. Below I have outlined my clinical activities.
Jose Miravet-Valenciano is laboratory manager in Igenomix and he is also heading several research projects related to endometrial receptivity under the supervision of Dr. Carlos Simón.
His career in the company started in the ERA department in Spain and has also been responsible for the Igenomix laboratory in México.
He has published several papers in prestigious medical journals and chapters in specialized books in the field of reproductive medicine such as Fertility and Sterility, Cold Spring Harbor perspectives in medicine and The Endometrial Factor, A Reproductive Precision Medicine Approach.
He has also been a Marie Curie Fellow at Karolinska Institutet (senior researcher) where he carried out an outstanding research about biomarkers related to endometrial receptivity being part of the team of Kristina Gemzell, from the Department of Women's and Children's Health (KBH).
Dr. Alshaikh is an Assistant Professor of Paediatric Neurology and Neuromuscular Disorders Specialist at King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, King Abdulaziz Medical City, Jeddah, Saudi Arabia. Prior to her current position, she did her clinical research fellowship in neuromuscular disorders and electromyography at the Dubowitz Neuromuscular Centre and Great Ormond Street NHS Trust, University College of London UCL, London, UK. Nahla is on a mission to raise awareness about neuromuscular disorders; working to maintain good quality national neuromuscular service and establishing collaborative clinical and research work. Her main field of interest is Duchenne Muscular Dystrophy and muscle MRI as an Outcome Measures in Neuromuscular Disorders.
Dr. Aldirbashi is board-certified in Biochemical Genetics by the American Board of Medical Genetics, the Canadian College of Medical Geneticists and the European American Board of Medical Genetics. He received assorted training in biochemical genetics, inborn errors of metabolism, newborn screening, bioanalytical chemistry and genetics at various renowned institutions in Canada, USA, Japan the Middle East.
Over the past fifteen years, Dr. Aldirbashi played key roles in the development of major newborn screening programs for inborn errors of metabolism in the Middle East and North America. He has extensive expertise in the screening and diagnosis of amino acid disorders, fatty acid oxidation disorders, organic acidurias and peroxisomal and lysosomal storage disorders.
Currently, Dr. Aldirbashi is an Assistant Professor of Pediatrics at the UAE University College of Medicine and Health Sciences. His research is focused on studying inborn errors of metabolism with special interest in organic acidurias and peroxisomal diseases. To date, Dr. Al-Dirbashi has published more than 65 articles in peer reviewed journals.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
Rob Taylor obtained his first degree in Biochemistry and his PhD in Molecular Genetics from Newcastle University where he was appointed as a Lecturer in 2001. He is currently Professor of Mitochondrial Pathology at the Wellcome Centre for Mitochondrial Research in Newcastle and an Honorary Consultant Clinical Scientist with the Newcastle upon Tyne Hospitals NHS Foundation Trust, leading the NHS Highly Specialised Mitochondrial Laboratory which provides a UK-wide diagnostic service for patients with mitochondrial disease. He is also Scientific Director of the NHS-led Genomic Laboratory Hub for Yorkshire and the North East, responsible for the provision of diagnostic genetics and genomics to a local population of ~9 million individuals.
His research laboratory focuses on the biochemical and molecular genetic investigation of human mitochondrial disorders, with interests ranging from determining the molecular mechanisms by which inherited mitochondrial genetic abnormalities cause cellular dysfunction and identifying new genes associated with both paediatric-onset and adult-onset mitochondrial disease presentations to the development of techniques to prevent the transmission of serious mitochondrial disease. His laboratory has identified and characterised more than 20 novel Mendelian causes of mitochondrial disease, leading to the publication of >420 peer-reviewed papers.
Professor of Ophthalmology Research Institute of Ophthalmology
Dr. BEN-OMRAN received his speciality training in clinical & metabolic genetics at the Hospital for Sick Children, University of Toronto, Canada. He has obtained both FRCPS & FCCMG in Medical Genetics in 2006. Currently, he is a senior consultant and Head of Clinical and Metabolic Genetics at Hamad Medical Corporation. He is an Associate Professor at Weill Cornell Medical College, Qatar & New York-USA. He is also a Distinguished Visiting Scientist at Boston Children’s Hospital-USA.
He contributes to the body of published knowledge in clinical and metabolic genetics, with over 60 published articles in peer reviewed journals, book chapters and abstracts. He is reviewer for many clinical genetics journals.
He is an active clinical researcher, collaborating on projects with local, regional & international communities. He is a lead primary investigator in many high profile research projects & clinical trials to evaluate the long-term effects of enzyme replacement therapy in patients with different lysosomal storage disorders. His main scientific interests include genetics of brain malformation& microcephaly, white matter disorders, dysmorphology, autosomal recessive disorders. In addition, Dr. Ben-Omran is an external advisor and expert for E-HOD (European registry and network for homocystinurias and methylation defects).
He is recognized as an expert in genetic disorders of the Arab population. His national & international presence is clear. In 2013, he received the "Princess Aljawhara Center Award for The Best Research in Basic Genetics" the most competitive & prestigious awards. He received Research Award from MRC-HMC for Homocystinuria project and Stars of Excellence Award 2011 for both Pioneering Newborn Screening & specialized care of Genetic Diseases in the Middle East. Recently, awarded the Stars of Excellence in research 2014: Cutting Edge of Research in Medical Genetics.
He has memberships in many societies including: American Society of Human Genetics, European Society of Human Genetics, Society for the Study of Inborn Errors of Metabolism, Middle East Metabolic Genetic Group, the Middle East & North Africa Newborn Screening Initiative, Middle Eastern Lysosomal Storage Diseases Expert Council Advisory Board, Child Health Research Advisory Committee, International Society for Prenatal Diagnosis, Chairman of Middle East Metabolic Dieticians Group & Founder Member & Regional Representative of SSIEM Adult Metabolic Physicians Group.
Dr. Alhouly is a molecular Geneticist at Kuwait Medical Genetics Center (KMGC). His PhD in Clinical Genetics was awarded from the University of Birmingham (UK). He has completed his bachelor degree in the major of Human Genetics from University of Leeds and his Master degree was awarded in Medical Genetics from Glasgow University. Dr. Alhouly is working in molecular genetics laboratory and microarray laboratory in KMGC.
His research concentrated on genetics and epigenetics of bone sarcoma using different high-throughput techniques including microarray and NGS (RNA-Seq). Dr. Alhouly has different publications in the field of genetics and epigenetic of sarcoma.
Assistant Professor in Reproductive Endocrinology and Infertility and Obstetrics and Gynecology. Department of Obstetrics and Gynecology, Kuwait University Faculty of Medicine
Dr Abdulrahman Alserri has completed his medical school training in the Royal College of Surgeons in Ireland (RCSI). He then completed his residency training in Obstetrics and Gynecology and his fellowship training in Gynecologic Reproductive Endocrinology and Infertility (GREI) at McGill University in Montreal, Canada. Currently, he is an Assistant Professor in Kuwait University Faculty of Medicine and practices clinically at the Reproductive Medicine Unit in the Maternity Hospital - Kuwait. His research interests are in the field of reproductive medicine. He is an active educator both locally and internationally.
Dr. Adekunle Adekile, MBBS, PhD, FMCPaed, FRCP, FRCPCH. Professor, Department of Pediatrics, Faculty of Medicine, Kuwait University and Adjunct Professor, University of Abuja, Abuja, Nigeria
Dr. Adekile graduated from University of Ibadan Medical School, Ibadan Nigeria and had his Pediatric Residency Training at the Obafemi Awolowo University Teaching Hospital, Ile-Ife Nigeria. He had his post-doctoral Fellowship in Pediatric Hematology in Howard University Hospital, Washington, DC, USA. In 1990 he was the recipient of the Fogarty International Fellowship which took him to the Medical College of Georgia, Augusta, Ga, USA where he worked in Dr. Titus Huisman’s Molecular Genetics Laboratory and the Comprehensive Sickle Cell Center. Dr. Adekile moved to Kuwait in 1993. He is the Chairman of the Department of Pediatrics in Kuwait University and Head of the Pediatric Hematology Unit, Mubarak Al-Kabeer Hospital. He is the director of the Kuwait National Sickle Cell Disease Registry which was established in 2010. Prof. Adekile holds the fellowships of several Postgraduate Medical Colleges and memberships of many professional bodies and editorial boards. He holds a PhD degree in Cell Biology from the University of Maastricht, Netherlands. He has more than 130 publications in peer-reviewed journals.
I am a PhD student studying under the supervision of Professor Robert Taylor and Professor Robert McFarland. My passion for genetics has driven me to obtain a BSc Genetics degree from California State University Stanislaus and was later employed at the Kuwait Medical Genetics Centre. I worked in the Kuwait Newborn Screening Program for 3 years before continuing my postgraduate studies and was awarded an MSc Molecular Genetics and Diagnostics degree from the University of Nottingham. I worked for another year at the Kuwait Medical Genetics Centre before starting my PhD studies at Newcastle University focusing on diagnosing mitochondrial disease cases in Kuwait.
Dr. Ahmad Al-Serri is an Assistant Professor of Human Genetics based in the Faculty of Medicine, Kuwait University. Dr. Al-Serri obtained his degrees from the United Kingdom between the University of Leeds, Newcastle University and the London school of Economics and Political Sciences. His research interests concentrate on identifying genetic markers associated with metabolic diseases. His particular focus is obesity and he is working on elucidating the mechanisms and factors underlying the high prevalence of obesity in the Kuwaiti population.
1991-1995: High school Certificate, Ahmed Beshir Al-Romy High School
July 2000: Bachelor of Basic Medical science, Faculty of medicine, Kuwait University.
July 2003: MBBS, Faculty of medicine, Kuwait University.
May 2006: MCCEE, Candidate Number: 200611903.
June 2007: Neonatal Resuscitation Program (NRP) diploma certificate, Kuwait.
Febuary 2013: German Medical Board of Human Genetics (Facharzt für Humangentik; Münster Ort, Deutschland).
Febuary 2017: Basic Life Support (BLS), Kuwait.
July 2018: Pediatric Advance Life Support (PALS), Kuwait.
Since I joined Kuwait Medical Genetics Center (KMGC) in June 2005, I was exposed to a large number of patients having wide varieties of syndromes. I joined both satellite genetics clinics found in the 5 government hospital all over Kuwait, as well as in-patient’s consults at Maternity hospital, which is very near to KMGC. I was under supervision by consultants in medical genetics in both situations.
Dr. Ashraf Hosni Ibrahim has graduated from faculty of medicine, Ain Shams University, Egypt in 1990, where he also obtained his master degree in pediatrics in 1997. In 2016, he obtained his Doctorate degree in medical genetics from Alexandria University, Egypt.
From 1993 to 2014, he had been working as Pediatric specialist and senior clinical genetic researcher in the Human Genetics and Genome research Department affiliated to the National Research Center, Cairo, Egypt.
From 2003 to 2006 he joined the Wessex Regional Genetics Laboratory in Salisbury District Hospital affiliated to Southampton University, United Kingdom. Where he worked as a research assistant in UK Myeloma project and completed the practical work of his Doctorate degree.
In 2014, he joined the KMGC and working till now as a senior clinical cytogeneticist and member of the Birth defects Registry team of Kuwait.
Winner of the 1st Prize for the best Oral Presentation at the 5th Annual International Meeting of The African Society of Human Genetics, November 2nd-5th, 2007.
He has more than twenty years’ experience in clinical pediatrics, clinical genetics, clinical cytogenetics, and application of molecular cytogenetics techniques in various pediatrics disabilities of chromosomal origin.
He has more than three years’ experience in interphase FISH analysis, M-FISH, microarrays CGH and complex cytogenetic analysis of plasma cell from patients with multiple myeloma.
MBChB DCP FACP
Consultant Hematologist - Amiri Hospital
IP the national sickle cell desease research project
President of Kuwait Sickle Cell Disease Association
Dr. Hassan A Al-Jafar is a Consultant Hematologist in Amiri Hospital in Kuwait since 2002 in both clinical and laboratory aspects. He is an IP of the national sickle cell disease research project and the President of Kuwait Sickle Cell Disease Association.
Dr. Al-Jafar is running the national research project of sickle cell disease from the year 2012.
Many publications and new conclusions produced from this merit project by collebration team of specialist participate in the research work. He is along with other specialist in deferent medical aspects setting new protocols for investigation and treatment of sickle cell disease.
Graduated from Kuwait Faculty of Medicine 2002: bachelor of surgery and medicine.
Worked in Mubarak Hospital, internal medicine for 3 years and got part1 MRCP in 2008
2009 Joined the department of clinical biochemistry and metabolic medicine and was responsible for the lipid outpatient clinic in Mubarak hospital till 2014.
Finished the KIMS program for clinical biochemistry and metabolic medicine in 2014.
Specialist in the newborn screening laboratory at KMGC since 2015.
Qualified from Accreditation Canada as Accreditation surveyor for Kuwait accreditation directorate doing surveys to many governmental hospitals in Kuwait since 2015.
- Graduated from Kuwait university in 2018
- Major: molecular biology and forensic science.
- Graduated from warsha academic by Ministry of State for Youth Affairs in 2016.
Work in Kuwait genetic center as an Employee in Molecular Genetics Laboratory.
The ability to extraction DNA from different methods , sequencing and mutation detection by different techniques
Master’s in Molecular Biology (2019). Faculty of Science, Kuwait University
Bachelor of Molecular Biology (2008-2013). Faculty of Science, Kuwait University
Molecular Biology lab technician at Kuwait Genetic Center (2017-present):
Assisting with the diagnostics of genetic disorders, including Duchenne muscular dystrophy (DMD), Neurofibromatosis type I (NF1), Bardet-Biedl syndrome (BBS), DiGeorge Syndrome, Williams Syndrome, Rubinstein-Taybi syndrome, and Sotos syndrome.
Assisting the senior lab scientists with their investigations.
Using Multiplex Ligation-dependent Probe Amplification (MLPA) and Sanger sequencing to detect mutations
Performing data analysis
Certified lab technician by Kuwait Medical Licensing Department.
Experienced in carrying out molecular laboratory work, including DNA extraction, PCR, direct sequencing, MLPA, and SNP genotyping.
Volunteer work at Al-Kharafi Center for kids and adults with Special Needs (2014-2016)
Shakir is a specialist in clinical as well as molecular genetics. He is also a board certified clinical and anatomical pathologist. He achieved his MBBS from Kuwait University and went on to AP/CP at University of Saskatchewan, Canada, and then genetics at McMaster University, Ontario, Canada. He is currently working at the Kuwait Medical Genetics Center running a general, hemato-, and cancer genetics clinics and the unit head of the Molecular Pathology lab at Kuwait Cancer Control Center, Ministry of Health, State of Kuwait. He is a tutor and board member of the Kuwait Institute of Medical Specializations’ Pediatrics, Pathology, and Clinical Chemistry residency programs. He is also a member of several committees overseeing lab management, employment and purchases on a national level.
Dr. Suzanne Al-Bustan has completed her PhD in Human Genetics at the age of 25 years from the Duncan Guthrie Institute in Medical Genetics at Glasgow University in 1992. She is an associate professor of Human and Molecular Genetics in the Department of Biological Sciences and currently the Department Chair of Biological Sciences. She has published numerous papers in reputed journals and has been active in both scientific research and supervision of several graduate students in the areas of human genetics and molecular biology. Her main research interests are in the genetic association of candidate genes with complex traits, specifically dyslipidemia and subsequent disorders. The methods applied include re-sequencing of genes involved in the lipid transport (APO gene family) and metabolism (LPL) in order to identify variants that may increase the risk to develop dyslipidemia.